BioSpace News Archive

Business

ENDYMED appoints Dr. Ziv Karni, Founder of Alma Lasers as Expert Technology Advisor

Endymed Ltd, currently traded on Tel Aviv Stock Exchange, is pleased to announce the appointment of Dr. Ziv Karni as Expert Technology Advisor.

January 4, 2022
·
2 min read
Lone Star Bio

Natera to Webcast Live Presentation at the 40th Annual J.P. Morgan Healthcare Conference

Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that it will webcast a live presentation at the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022 at 1:30 p.m. PT (4:30 p.m. ET).

January 4, 2022
·
2 min read
Biotech Beach

Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference

DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 40th annual J.P. Morgan Healthcare Conference on January 10, 2022.

January 4, 2022
·
1 min read
Business

Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs

Champions Oncology, Inc. announced today a therapeutic development partnership with Alloy Therapeutics.

January 4, 2022
·
4 min read
Deals

Advanced Dermatology and Cosmetic Surgery Acquires Fort Mill Dermatology

Advanced Dermatology and Cosmetic Surgery has announced that Fort Mill Dermatology – the South Carolina practice led by Board Certified Dermatologist Rebecca Smith – MD has joined its brand family of 150+ offices nationwide.

January 4, 2022
·
3 min read
Business

Genmab and Synaffix Enter into License Agreement for ADC Technology

Genmab A/S (Nasdaq: GMAB) and Synaffix B.V., announced today that Genmab and Synaffix have signed a license agreement providing Genmab broad access to Synaffix’s ADC technologies.

January 4, 2022
·
6 min read
BioCapital

Privia Health to Participate in 40th Annual J.P. Morgan Healthcare Conference

Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference.

January 4, 2022
·
1 min read
Business

Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced the appointment of Elizabeth Yeu, M.D. to its Board of Directors.

January 4, 2022
·
5 min read
Pharm Country

Ansys and Innoviz Technologies Enable Autonomous Driving Revolution with Next-Gen LiDAR Design

Innoviz Technologies is using Ansys (NASDAQ: ANSS) simulation solutions to successfully drive the technology behind their unique automotive-grade LiDAR sensor and achieve autonomy for their customers—while reducing development time and costs.

January 4, 2022
·
4 min read
Business

Artiva Biotherapeutics Strengthens Leadership Team with the Appointment of Christopher Horan as Chief Technical Operations Officer

Artiva Biotherapeutics, Inc., an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, today announced the appointment of Christopher Horan as Chief Technical Operations Officer.

January 4, 2022
·
3 min read